High-Purity N-Boc-piperidine-3-methanol (CAS 116574-71-1): Pharmaceutical Intermediate Supplier

Discover N-Boc-piperidine-3-methanol, a crucial building block for pharmaceutical synthesis. Explore its properties, applications, and how to source this vital intermediate from reliable manufacturers and suppliers.

Get a Quote & Sample

Advantages of Sourcing N-Boc-piperidine-3-methanol

Chemical Purity and Consistency

Our commitment as a manufacturer ensures that N-Boc-piperidine-3-methanol meets stringent purity standards (>97%), critical for successful pharmaceutical applications and reproducible research results. We provide comprehensive COA for every batch.

Extensive Application Potential

This compound serves as a key reactant in the synthesis of various pharmacologically active molecules, making it invaluable for drug discovery pipelines targeting diverse therapeutic areas. We facilitate the purchase of this intermediate for your innovation.

Stable Supply Chain and Global Reach

As a dedicated supplier, we guarantee a stable and continuous supply of N-Boc-piperidine-3-methanol, supported by efficient logistics to meet your project timelines. Connect with us to buy and secure your requirements.

Key Applications in Pharmaceutical Synthesis

Pim-1 Inhibitor Synthesis

N-Boc-piperidine-3-methanol is a crucial building block for synthesizing potent Pim-1 inhibitors, vital in cancer research and therapy. Partner with a reliable manufacturer to buy this essential component.

Vasopressin Receptor Antagonists

Its utility extends to the development of Vasopressin1b receptor antagonists, important for treating conditions related to water balance and blood pressure. Inquire about our supplier network for purchase.

CXCR4 Antagonists (Anti-HIV Agents)

This intermediate plays a role in creating CXCR4 antagonists, which are being explored as potential anti-HIV therapies. Explore competitive pricing from our wholesale suppliers.

Other Therapeutic Targets

It is also employed in the synthesis of Amide CCR5 antagonists and PSSRI-based inhibitors, demonstrating its broad applicability in medicinal chemistry and drug development.